p27 ACTIVATES CDK4 AND BLOCKS PALBOCICLIB-MEDIATED CDK4 INHIBITION

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2020年 / 10卷 / 02期
关键词：
D O I：
10.1158/2159-8290.CD-RW2020-001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：172 / 172
页数：1
相关论文
共 50 条
  • [41] MCL PATIENTS RESPOND TO CDK4/6 INHIBITION
    不详
    CANCER DISCOVERY, 2012, 2 (04) : 300 - 300
  • [42] The Role of CDK4/6 Inhibition in Breast Cancer
    Murphy, Conleth G.
    Dickler, Maura N.
    ONCOLOGIST, 2015, 20 (05): : 483 - U49
  • [43] Tankyrase inhibition sensitizes cells to CDK4 blockade
    Foronda, Miguel
    Tarumoto, Yusuke
    Schatoff, Emma M.
    Leach, Benjamin, I
    Diaz, Bianca J.
    Zimmerman, Jill
    Goswami, Sukanya
    Shusterman, Michael
    Vakoc, Christopher R.
    Dow, Lukas E.
    PLOS ONE, 2019, 14 (12):
  • [44] MGMT inhibition leads to CDK4/6 inhibition and enhances palbociclib and abemaciclib activity in breast cancer
    Bobustuc, George C.
    Kassam, Amin B.
    Rovin, Richard A.
    Donohoe, Deborah L.
    Albiero, Maxwell
    Jella, Tarun
    Fukui, Olivia
    Piron, Cameron
    Konduri, Santhi D.
    CANCER RESEARCH, 2017, 77
  • [45] Mechanisms of Sensitivity and Resistance to CDK4/6 Inhibition
    Alvarez-Fernandez, Monica
    Malumbres, Marcos
    CANCER CELL, 2020, 37 (04) : 514 - 529
  • [46] Targeting CDK4 and CDK6 in cancer
    Shom Goel
    Johann S. Bergholz
    Jean J. Zhao
    Nature Reviews Cancer, 2022, 22 : 356 - 372
  • [47] CDK4/6 inhibition in luminal breast cancer
    Gampenrieder S.P.
    Rinnerthaler G.
    Greil R.
    memo - Magazine of European Medical Oncology, 2016, 9 (2) : 76 - 81
  • [48] CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas
    Pita, Jaime M.
    Raspe, Eric
    Coulonval, Katia
    Decaussin-Petrucci, Myriam
    Tarabichi, Maxime
    Dom, Genevieve
    Libert, Frederick
    Craciun, Ligia
    Andry, Guy
    Wicquart, Laurence
    Leteurtre, Emmanuelle
    Tresallet, Christophe
    Marlow, Laura A.
    Copland, John A.
    Durante, Cosimo
    Maenhaut, Carine
    Cavaco, Branca M.
    Dumont, Jacques E.
    Costante, Giuseppe
    Roger, Pierre P.
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [49] Molecular dissection of CDK4/CyclinD1 regulation: Prevention of pathway hyperactivation by continuous CDK4/6 inhibition
    Gharbi, S.
    Gutierrez, J.
    Espada, A.
    Gutierrez, S. M.
    Torres-Guzman, R.
    Debets, M. F.
    Prieto, L.
    Du, J.
    De Dios, A.
    Lallena, M. J.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E45 - E45
  • [50] CDK4/6 inhibitor palbociclib suppresses IgE-mediated mast cell activation
    Yi-Bo Hou
    Kunmei Ji
    Yue-Tong Sun
    Li-Na Zhang
    Jia-Jie Chen
    Journal of Translational Medicine, 17
12345